KIA
ALT icon

Kraematon Investment Advisors’s Altimmune ALT Stock Holding History

Kraematon Investment Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,435
Closed -$65.7K – 103
2025
Q3 		$65.7K Sell
17,435
-16,150
-48% -$62.4K 0.06% 100
2025
Q2 		$130K Sell
33,585
-1,500
-4% -$8.12K 0.12% 89
2025
Q1 		$175K Buy
35,085
+4,300
+14% +$27.2K 0.18% 86
2024
Q4 		$222K Buy
+30,785
New +$235K 0.22% 81

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Kraematon Investment Advisors's ALT Position: Q4 2025 in Review

Kraematon Investment Advisors sold out of Altimmune (ALT) in Q4 2025, closing a stake of 17,435 shares — an estimated $65.7K sold.

Kraematon Investment Advisors first reported a position in ALT in Q4 2024 and held it in 4 quarters. The position peaked at $222K in Q4 2024. 181 funds tracked by Wall St. Rank hold ALT as of Q4 2025.

  • Kraematon Investment Advisors reported no remaining Altimmune position as of Q4 2025 after selling out during the quarter.
  • Kraematon Investment Advisors sold 17,435 Altimmune shares in Q4 2025, an estimated $65.7K.
  • Kraematon Investment Advisors first reported a position in Altimmune in Q4 2024 and held it in 4 quarters.
  • Kraematon Investment Advisors's Altimmune position peaked at $222K in Q4 2024.
  • 181 funds tracked by Wall St. Rank held Altimmune as of Q4 2025.

Based on Kraematon Investment Advisors's 13F filing for Q4 2025, filed 21 Jan 2026.